Jonathan Chow, MD
Critical Care Medicine · Washington, DCNPI 1275809261
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $178,167 of the $285,120 with a category attached, or 62.5%. La Jolla Pharmaceutical Company accounts for 65.8% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $87,685 and has fallen 75.5% since, to $21,493 in 2025. Among critical care medicine clinicians in DC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 196 payments — averaging $1454.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- La Jolla Pharmaceutical Company$188K
- Exthera Medical Corporation$68K
- Hemosonics LLC$29K
- Partner Therapeutics, Inc.$350
- Shionogi Inc$123
- Chiesi USA, Inc.$103
- plus $40 from 1 others
What the payments were for
- Consulting fees$78,39927%
- Speaking & faculty fees$178,16762%
- Travel & lodging$24,2799%
- Food & beverage$4,2751%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| La Jolla Pharmaceutical Company | 162 | $187,735 |
| Exthera Medical Corporation | 15 | $67,719 |
| Hemosonics LLC | 15 | $29,049 |
| Partner Therapeutics, Inc. | 1 | $350 |
| Shionogi Inc | 1 | $123 |
| Chiesi USA, Inc. | 1 | $103 |
| Edwards Lifesciences | 1 | $40 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GIAPREZA$182,508
- QUNATRA QPLUS SYSTEM$28,100
- Quantra QPlus System$17,179
- Xerava$2,815
- Leukine$350
- Fetroja$123
- CLEVIPREX$103
How this compares
$285,120 in reported general payments places this provider in the 95th percentile of 59 critical care medicine providers in District of Columbia.
See all critical care medicine providers in District of Columbia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Washington
- Lakhmir ChawlaWashington$441K
- Tunay KuruWashington$81K
- Vivek JainWashington$14K
- Kellen MulhernWashington$10K
- Jacob CollenWashington$8K
- Danielle DavisonWashington$5K
- Andrew HillWashington$5K
- Dina KianouryWashington$5K
- Brian LeeWashington$3K
- Pramod BhattaraiWashington$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.